These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Expression of peroxisome proliferators-activated receptor-gamma and cyclooxygenase-2 in Helicobacter pylori infection-associated diseases and significance thereof]. Xie Y, Zhu J, Zhou XJ, Chen J, Lu NH, Wang CW. Zhonghua Yi Xue Za Zhi; 2006 Oct 17; 86(38):2683-9. PubMed ID: 17199977 [Abstract] [Full Text] [Related]
4. Effect of Helicobacter pylori infection on IL-8, IL-1beta and COX-2 expression in patients with chronic gastritis and gastric cancer. Bartchewsky W, Martini MR, Masiero M, Squassoni AC, Alvarez MC, Ladeira MS, Salvatore D, Trevisan M, Pedrazzoli J, Ribeiro ML. Scand J Gastroenterol; 2009 Oct 17; 44(2):153-61. PubMed ID: 18985541 [Abstract] [Full Text] [Related]
5. Cyclooxygenase-2 expression in gastric antral mucosa before and after eradication of Helicobacter pylori infection. McCarthy CJ, Crofford LJ, Greenson J, Scheiman JM. Am J Gastroenterol; 1999 May 17; 94(5):1218-23. PubMed ID: 10235197 [Abstract] [Full Text] [Related]
6. Up-regulation of cathepsin X in Helicobacter pylori gastritis and gastric cancer. Krueger S, Kalinski T, Hundertmark T, Wex T, Küster D, Peitz U, Ebert M, Nägler DK, Kellner U, Malfertheiner P, Naumann M, Röcken C, Roessner A. J Pathol; 2005 Sep 17; 207(1):32-42. PubMed ID: 16025436 [Abstract] [Full Text] [Related]
12. Significance of cell-surface expression of matrix metalloproteinases and their inhibitors on gastric epithelium and infiltrating mucosal lymphocytes in progression of Helicobacter pylori-associated gastritis. Koyama S. Scand J Gastroenterol; 2004 Nov 01; 39(11):1046-53. PubMed ID: 15545160 [Abstract] [Full Text] [Related]
13. Helicobacter pylori infection upregulates endothelial nitric oxide synthase expression and induces angiogenesis in gastric mucosa of dyspeptic patients. Lazaraki G, Kountouras J, Metallidis S, Vrettou E, Tzioufa V, Germanidis G, Chatzopoulos D, Zavos C, Giannoulis K, Nikolaidis P. Eur J Gastroenterol Hepatol; 2008 May 01; 20(5):441-9. PubMed ID: 18403947 [Abstract] [Full Text] [Related]
14. [Helicobacter pylori and the progression of gastric cancer: a 10-year cohort study]. Ma JL, Zhang L, Pan KF, Liu WD, Feng GS, You WC. Zhonghua Yi Xue Za Zhi; 2005 Oct 19; 85(39):2758-61. PubMed ID: 16324316 [Abstract] [Full Text] [Related]
16. Effect of probiotics and triple eradication therapy on the cyclooxygenase (COX)-2 expression, apoptosis, and functional gastric mucosal impairment in Helicobacter pylori-infected Mongolian gerbils. Brzozowski T, Konturek PC, Mierzwa M, Drozdowicz D, Bielanski W, Kwiecien S, Konturek SJ, Stachura J, Pawlik WW, Hahn EG. Helicobacter; 2006 Feb 19; 11(1):10-20. PubMed ID: 16423085 [Abstract] [Full Text] [Related]
17. Vascular endothelial growth factor and neo-angiogenesis in H. pylori gastritis in humans. Tuccillo C, Cuomo A, Rocco A, Martinelli E, Staibano S, Mascolo M, Gravina AG, Nardone G, Ricci V, Ciardiello F, Del Vecchio Blanco C, Romano M. J Pathol; 2005 Nov 19; 207(3):277-84. PubMed ID: 16184519 [Abstract] [Full Text] [Related]
18. Effect of H. pylori on COX-2 expression in gastric remnant after distal gastrectomy. Fukuhara K, Osugi H, Takada N, Takemura M, Lee S, Morimura K, Taguchi S, Kaneko M, Tanaka Y, Fujiwara Y, Nishizawa S, Fukushima S, Kinoshita H. Hepatogastroenterology; 2004 Nov 19; 51(59):1515-8. PubMed ID: 15362790 [Abstract] [Full Text] [Related]